New biologic drug brazikumab tested for Crohn's – trial cut short
NCT ID NCT03759288
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested brazikumab, an experimental biologic drug, in 89 adults with moderate-to-severe Crohn's disease. Participants received either brazikumab, a placebo, or an active comparator (Humira) to see if the drug could improve symptoms and heal the gut lining. The trial was terminated early, so the full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Brazikumab (a biologic drug given by IV and then injection)
What this could lead to
If successful, brazikumab could offer a new treatment option to reduce symptoms and gut inflammation in people with moderate-to-severe Crohn's disease.
What could go wrong
This trial was terminated early, so results are limited. As a phase 2b/3 study, it is still experimental, and the drug may not prove effective or safe enough for approval.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Phoenix, Arizona, 85037, United States
-
Research Site
Little Rock, Arkansas, 72212, United States
-
Research Site
Lancaster, California, 93534, United States
-
Research Site
Lincoln, California, 95648, United States
-
Research Site
Poway, California, 92064, United States
-
Research Site
San Diego, California, 92103, United States
-
Research Site
Colorado Springs, Colorado, 80907, United States
-
Research Site
Boca Raton, Florida, 33487, United States
-
Research Site
Clearwater, Florida, 33756, United States
-
Research Site
Kissimmee, Florida, 34741, United States
-
Research Site
Lakeland, Florida, 33813, United States
-
Research Site
Miami, Florida, 33157, United States
-
Research Site
Miami, Florida, 33165, United States
-
Research Site
Miami, Florida, 33189, United States
-
Research Site
Miami Lakes, Florida, 33016, United States
-
Research Site
Naples, Florida, 34102, United States
-
Research Site
St. Petersburg, Florida, 33710, United States
-
Research Site
Tampa, Florida, 33626, United States
-
Research Site
Atlanta, Georgia, 30328, United States
-
Research Site
Atlanta, Georgia, 30342, United States
-
Research Site
Decatur, Georgia, 30033, United States
-
Research Site
Oak Lawn, Illinois, 60453, United States
-
Research Site
Brownsburg, Indiana, 46112, United States
-
Research Site
Chesterfield, Michigan, 48047, United States
-
Research Site
Las Vegas, Nevada, 89123, United States
-
Research Site
Albuquerque, New Mexico, 87108, United States
-
Research Site
Morehead City, North Carolina, 28557, United States
-
Research Site
Beachwood, Ohio, 44122, United States
-
Research Site
Oklahoma City, Oklahoma, 73102, United States
-
Research Site
Uniontown, Pennsylvania, 15401, United States
-
Research Site
Carrollton, Texas, 75007, United States
-
Research Site
Houston, Texas, 77017, United States
-
Research Site
Houston, Texas, 77058, United States
-
Research Site
McAllen, Texas, 78503, United States
-
Research Site
Pflugerville, Texas, 78660, United States
-
Research Site
Stafford, Texas, 77477, United States
-
Research Site
North Chesterfield, Virginia, 23236, United States
-
Research Site
Spokane, Washington, 99204, United States
-
Research Site
New Westminster, British Columbia, V3L 3W4, Canada
-
Research Site
Chicoutimi, Quebec, G7H 5H6, Canada
-
Research Site
České Budějovice, 370 01, Czechia
-
Research Site
Hořovice, 268 31, Czechia
-
Research Site
Hradec Králové, 500 12, Czechia
-
Research Site
Olomouc, 772 00, Czechia
-
Research Site
Augsburg, 86156, Germany
-
Research Site
Berlin, 10825, Germany
-
Research Site
Hamburg, 20251, Germany
-
Research Site
Kiel, 24105, Germany
-
Research Site
Minden, 32423, Germany
-
Research Site
Remscheid, 42859, Germany
-
Research Site
Ulm, 89081, Germany
-
Research Site
Budapest, 1082, Hungary
-
Research Site
Bangalore, 560054, India
-
Research Site
Hyderabad, 500032, India
-
Research Site
Jaipur, 302001, India
-
Research Site
Surat, 395002, India
-
Research Site
Haifa, 3109601, Israel
-
Research Site
Jerusalem, 9103102, Israel
-
Research Site
Petah Tikva, 4941492, Israel
-
Research Site
Milan, 20132, Italy
-
Research Site
Milan, 20154, Italy
-
Research Site
Padova, 35128, Italy
-
Research Site
Rozzano, 20089, Italy
-
Research Site
Bydgoszcz, 85 168, Poland
-
Research Site
Chojnice, 89-600, Poland
-
Research Site
Krakow, 31-513, Poland
-
Research Site
Poznan, 61-731, Poland
-
Research Site
Rzeszów, 35-302, Poland
-
Research Site
Sopot, 81-756, Poland
-
Research Site
Torun, 87-100, Poland
-
Research Site
Warsaw, 00-189, Poland
-
Research Site
Warsaw, 00-728, Poland
-
Research Site
Warsaw, 03-580, Poland
-
Research Site
Wroclaw, 52-210, Poland
-
Research Site
Zamość, 22-400, Poland
-
Research Site
Aramil, 624002, Russia
-
Research Site
Moscow, 115419, Russia
-
Research Site
Perm, 614000, Russia
-
Research Site
Banská Bystrica, 97401, Slovakia
-
Research Site
Košice, 04013, Slovakia
-
Research Site
Nitra, 94901, Slovakia
-
Research Site
Cape Town, 7500, South Africa
-
Research Site
Cape Town, 7708, South Africa
-
Research Site
Johannesburg, 1827, South Africa
-
Research Site
Plumstead, 7800, South Africa
-
Research Site
Busan, 48108, South Korea
-
Research Site
Daegu, 42415, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
Seoul, 156-755, South Korea
-
Research Site
Madrid, 28046, Spain
-
Research Site
Pontevedra, 36071, Spain
-
Research Site
Valencia, 46010, Spain
-
Research Site
Kaohsiung City, 80756, Taiwan
-
Research Site
Taichung, 40447, Taiwan
-
Research Site
Taipei, 100, Taiwan
-
Research Site
Taipei, 114, Taiwan
-
Research Site
Kharkiv, 61037, Ukraine
-
Research Site
Kyiv, 03680, Ukraine
-
Research Site
Kyiv, 04050, Ukraine
-
Research Site
Kyiv, 04078, Ukraine
-
Research Site
Coventry, CV2 2DX, United Kingdom
-
Research Site
West Bromwich, B71 4HJ, United Kingdom